+499.5%
MRNA vs FITB
+23.7%
+475.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FITB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.2% | -2.0% | -2.4% |
| 7D | +5.5% | +0.6% | +4.9% | +6.1% |
| 30D | +158.7% | -4.7% | +163.5% | +156.4% |
| 3M | +182.1% | +6.7% | +175.5% | +167.0% |
| 6M | +151.8% | +12.6% | +139.3% | +131.0% |
| YTD | +393.6% | +19.1% | +374.4% | +333.7% |
| 1Y | +499.5% | +22.6% | +476.8% | +367.2% |
| All | +499.5% | +23.7% | +475.8% | +367.2% |
Cumulative growth
Daily Returns
Daily percentage return beside FITB.
Daily Out/Under-Performance
Portfolio return minus FITB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FITB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FITB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling